AllDocs -> cancers

570 MJA Vol 176 17 June 2002 EDITORIALS The AMA believes that, as a general principle, advertise- ments must be honest, must not exploit patients’ vulnerabil- ity or lack of medical knowledge, and should provide only factual information. Any advertisement for a doctor’s serv- ices should present information that is reasonably necessary for making an informed decision about the appropriateness and availability of the medical services offered. 6 In recognition of the need for a middle ground between the traditional ban on advertising and the current deregu- lated environment, the Medical Practitioners Board of Victoria has produced draft guidelines which will provide clear guidance for doctors who wish to advertise their services. A summary of the guidelines is presented in the Box. 7 Whether we agree with changes in contemporary views which ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com * Findings were statistically significant (strong evidence) + Evidence of a dose-response relationship (strongest evidence) Page 100 Thyroid Cancer and other Thyroid Diseases and Exposure to Ionizing Radiation Summary: Strong evidence has been recorded of a possible connection between thyroid cancer and exposure to ionizing radiation. This evidence is based upon studies conducted at Los Alamos National Laboratory, studies of nuclear workers at other sites, and others exposed to ionizing radiation. These findings are consistent with the National Research Council’s determination that the thyroid is sensitive to ionizing radiation. Thyroid cancer is designated as a “specified” cancer under the Energy Employees ...

1 TRENDS IN THYROID CANCER IN SWITZERLAND: COULD A CHERNOBYL EFFECT BE DISCLOSED? Fabio Montanaro 1 , Pierre Pury 2 , Andrea Bordoni 1 , Jean-Michel Lutz 2,3 and the Swiss network of cancer registries (ASRT) 1 Ticino Cancer Registry, Locarno 2 Association of Swiss Cancer Registries, Geneva 3 Geneva Cancer Registry, Geneva Carcinoma of the thyroid gland is an uncommon malignancy, accounting for approximately 1% of total cancer cases in developed countries (WCR 2003). In areas not associated with nuclear fallout (how do you define this, or do list them), the annual incidence of thyroid cancer ranges between 2.0-3.8 cases per 100,000 in women and 1.2- 2.6 per 100,000 in men, women of childbearing age being at highest risk. Low figures are ...

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service National Institutes of Health National Cancer Institute Bethesda, Maryland 20892 May 9,200l Mr. Barrett Fountos, M.S. Health Scientist Office of International Heaith Programs U.S. Department of Energy 19900 1 Germantown Road EH-63/270 CC Germantown, MD 20874 Dear Mr. Fountos: On behalf of the National Cancer Institute (NC& I would like to invite you to attend the “International Workshop on Chomobyl Thyroid Cancer Activities,” which will be held on lo- 11 September, 200 1, in Bethesda, Maryland. The NC1 is currently participating in two collaborative thyroid disease investigations associated with Chomobyl exposures, one in Belarus and one in Ukraine. NC1 scientists believe there would be great benefit in convening a workshop of the leaders from other organizations actively ...

Investigation of Excess Thyroid Cancer Incidence in Los Alamos County Final Report Prepared by William F. Athas, PhD Division of Epidemiology, Evaluation, and Planning New Mexico Department of Health April 1996 This study was supported by funds from the Office of Epidemiology and Health Surveillance, U.S. Department of Energy; Grant No. DE-FG04-91AL75237. Page 2 ACKNOWLEDGMENTS The author would like to extend thanks to the members of the Thyroid Cancer Technical Steering Sub Committee for their helpful comments and criticisms (Scott Davis, PhD; Earl Ford, MD; Frank Gilliland, MD; Don Morris, MD; Gerry Petersen, PhD; and Helen Stanbro; MS); to Michael Jackson, MD at the Los Alamos Medical Center for valuable discussions regarding thyroid surgery; to George Voelz, MD; and Laurie Wiggs, PhD, at the Los Alamos National Laboratory ...

84 19 Cancer of the thyroid Summary Relative survival after diagnosis of thyroid cancer is high, when compared with other cancer sites. During 1992–1997, relative survival one year after diagnosis of cancer of the thyroid was 91.2% for males and 96.4% for females. Five-year relative survival was 87.9% for males and 95.6% for females (Table 19.1). Survival ten years after diagnosis was 79.8% for males and 92.2% for females in 1987–1991, the most recent period for which ten-year relative survival data are available (Figure 19.2; Tables 19.2 and 19.3). Between 1982–1986 and 1992–1997, relative survival for females increased significantly with five-year relative survival increasing from 87.8% to 95.6%. For males the only significant increase was for relative survival three years after diagnosis, from 83.2% to 89.6% (Figure 19.2; Tables 19.2 and 19.3). Five-year relative survival after ...

THYROID CANCER MEDICAL APPENDIX DEFINITION 1 Thyroid nodules are common with a spectrum ranging from benign to malignant. Some nodules are true benign adenomas and others are definite carcinomas but between these many nodules are potentially malignant and the precise relationship between benign and malignant nodules is speculative. Although relatively rare, accounting for less than 1% of new malignancies annually in Britain, thyroid cancer is the most common type of endocrine malignancy. Cancers of the thyroid are usually classified into the following histological groups: • Papillary carcinoma • Follicular carcinoma • Medullary carcinoma • Anaplastic carcinoma 2 Malignancies of other tissues may also occur in the thyroid gland: 2.1. Miscellaneous tumours . The thyroid may be the site of non-Hodgkin’s lymphoma, which accounts for up to 50% of ...

Radioiodine (I131)Treatment for Thyroid Cancer Patient Information Page 1 of 6 The Northern Centre for Cancer Treatment Radioiodine (I131) Treatment for Thyroid Cancer This information sheet has been designed to provide you with some useful information about your admission to the Northern Centre for Cancer Treatment for I131treatment. This leaflet explains: Where you will have your treatment How your treatment is given Special precautions that will need to be taken Possible side effects Discharge arrangements Whyam I having I131? Yourconsultant will have discussed the reasons whyyou have been advised to have I131, including what would happen ifyou chose notto have this treatment. You will also have been given some National patient information about this type of treatment (British Thyroid Association 2004). If you have anyfurther questions then you should ...

91 Arq Bras Endocrinol Metab vol 50 nº 1 Fevereiro 2006 ABSTRACT Thyroxine (T4) withdrawal or recombinant TSH is used for the stimulation of thyroglobulin (Tg), whole-body scanning (WBS) and iodine-131 treatment in patients with thyroid carcinoma. This study evaluated the T4 dose reduction protocol as an alternative for patients’ preparation. Fifty-one patients were submitted to total T4 withdrawal for WBS and Tg measure- ment. T4 treatment was then resumed and maintained until TSH reached levels = 0.3 mIU/l. The T4 dose was then decreased to 0.8 µg/kg/day and TSH was measured weekly. Tg was assayed when TSH was > 30 mIU/l. Patients diagnosed with the disease upon initial evaluation were treated. We also evaluated the clinical and laboratory changes observed for both preparations. Using the reduced dose protocol, TSH levels > 30 mIU/l were reached within 6 and 8 weeks in 84.6 and 100% of ...

Therapeutic Approaches to Patients with Advanced Thyroid Cancer Kenneth B. Ain Supported by an unrestricted educational grant from Abbott Laboratories 191 193 191 Page 2 Page 3 Therapeutic Approaches to Patients With Advanced Thyroid Cancer Kenneth B. Ain, M.D. Thyroid Cancer Research Laboratory, Veterans Affairs Medical Center; Director, Thyroid Oncology Section Division of Hematology & Oncology University of Kentucky Medical Center Lexington, KY Clinical Approach • Micro-dissect the clinical history œ Review and verify the pathology • Slide review by expert pathologist • Immunohistochemistry if needed œ Document each radiological exam • Iodinated contrast decreases radioiodide uptake • Delineate all sites ...

"Radiation & Risk", 1996, issue 8 Scientific Articles 15 Leukemia and thyroid cancer in emergency workers of the Chernobyl accident: estimation of radiation risks (1986-1995) Ivanov V.K., Tsyb A.F., Gorsky A.I., Maksyutov M.A., Rastopchin Eu.M., Konogorov A.P., Korelo A.M., Biryukov A.P., Matyash V.A. Medical Radiological Research Centre of RAMS, Obninsk The work makes a direct epidemiological assessment of radiation risks in induction of leukemia and thyroid cancer in emergency workers after the Chernobyl accident. The Russian National Medical Dosimetric Registry has a compilation of data for 168 thousand emergency workers as of 01.01.1996. Analysis was per- formed of 48 leukemias and 47 thyroid cancers diagnosed and verified in emergency workers. The estimated radiation risks are: for leukemia - excess relative risk per Gy (ERR/Gy) is 4.30 (95% ...

!"# !$%&'%(!)* #+%,!-./)01%2!34).3#+%5$6.1/ '%7! 6.3!1 Waikato District Health Board Thyroid cancer Mortality (0-74) Introduction Rationale Methodology Data Coverage Period Method Description Interpretation International Classification of Disease Codes (ICD Version 9 & 10) ICD 9 ICD 10 Findings 1 Ethnicity Volume Trend 2 Age Gender Volume Proportion Profile 3 Age Ethnicity Volume Profile - All years 4 Age Ethnicity Volume Proportion Profile (All Years) 5 Age Standardised Trend - Waikato District Health Board versus NZ rate per 10,000 persons 6 Maori Age Standardised Trend - Waikato District Health Board versus NZ rate per 10,000 persons 7 Paciifc People Age Standardised Trend - Waikato District Health Board versus NZ rate per 10,000 persons 8 Other Ethnicity Age Standardised Trend - Waikato District Health Board ...

TBILISI STATE MEDICAL UNIVERSITY ANNALS OF BIOMEDICAL RESEARCH AND EDUCATION 2003 April/June, Volume 3, Issue 2 The Changes of pH and Partial Pressure of Oxygen in Blood at Chronic Heart Failure Nino Mamamtavrishvili*, Giorgi Red'ko**, Gulnara Tabidze*, Marina Iakobashvili* * Scientific-Research Institute of Cardiology, Tbilisi, Georgia, **TSMU Scientific-Research Institute of Experimental Medicine, Tbilisi, Georgia Abstract Disorders in myocardium metabolism taking place at heart failure are connected with reduced blood supply and promote decrease of ATP production, breaking of oxygen consumption, increase of lactate and hydrogen ions' production. In this connection study of changes of partial pressure of oxygen ions occurring in blood of patients with systolic and diastolic forms of heart failure seems to be of great interest. On the basis of obtained results ...